ARCH Venture Management, LLC

ARCH Venture Management, LLC reported 17 holdings worth US$1.61B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

ARCH Venture Management, LLC reported 17 holdings worth US$1.61B as of Sep 30, 2026. Largest: Kardigan, Inc., Parabilis Medicines, Inc. and Vir Biotechnology, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
17
Value as reported
US$1.61B

The filing in full

CompanySharesValue as reported% of portfolio
Kardigan, Inc.15MUS$222M13.8%
Parabilis Medicines, Inc.6.41MUS$207M12.8%
Vir Biotechnology, Inc.12.7MUS$142M8.8%
Sana Biotechnology, Inc.45.9MUS$134M8.3%
Seaport Therapeutics, Inc.6.29MUS$127M7.9%
Rapport Therapeutics, Inc.3.73MUS$125M7.8%
Scholar Rock Holding Corporation2.35MUS$113M7.0%
Maze Therapeutics, Inc.4.12MUS$112M6.9%
Beam Therapeutics Inc.4.54MUS$111M6.9%
Erasca, Inc.7.09MUS$104M6.4%
908 Devices Inc.5.73MUS$70.6M4.4%
Prime Medicine, Inc.18.5MUS$56.5M3.5%
Lyell Immunopharma, Inc.3.25MUS$31.8M2.0%
Generate Biomedicines, Inc.1.94MUS$29.2M1.8%
Neumora Therapeutics, Inc.33.8MUS$20.2M1.3%
Boundless Bio, Inc.2.69MUS$6.76M0.42%
10x Genomics, Inc.0US$00.00%
Gossamer Bio, Inc.0US$00.00%

Source

Download original · View original at SEC

Related